Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study
Texas Heart Institute Journal · 2023
DOI: 10.14503/thij-22-7866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Texas Heart Institute Journal, 2023. Verfasst von Eliana Rosenzweig und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New Y…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Patients with pulmonary arterial hypertension have quality-of-life limitations, decreased exercise capacity, and poor prognosis if the condition is left untreated. Standard exercise testing is routinely performed to evaluate patients with pulmonary arterial hypertension but may be limited in its ability to monitor activity levels in daily living.
Objective
To evaluate the validity of the commercial Fitbit Charge HR as a tool to assess real-time exercise capacity as compared with standard exercise testing.
Methods
Ambulatory pediatric and adult patients were enrolled and given a Fitbit with instructions to continuously wear the device during waking hours. Patients underwent a 6-minute walk test, cardiopulmonary exercise test, and a 36-Item Short Form Health Survey on the day of enrollment and follow-up. Twenty-seven ambulatory patients with pulmonary arterial hypertension were enrolled, and 21 had sufficient data for analyses (median age, 25 years [range, 13-59 years]; 14 female participants).
Results
Daily steps measured by the Fitbit had a positive correlation with 6-minute walk distance ( r = 0.72, P = .03) and an inverse trend with World Health Organization functional class. On the 36-Item Short Form Health Survey, 77% of patients reported improvement in vitality ( P = .055). At follow-up, there was a strong correlation between number of steps recorded by Fitbit and role limitations because of physical problems ( r = 0.88, P = .02) and weaker correlations with other quality-of-life markers.
Conclusion
The findings of this pilot study suggest activity monitors may have potential as a simple and novel method of assessing longitudinal exercise capacity and activity levels in patients with pulmonary hypertension. Further study in larger cohorts of patients is warranted to determine which accelerometer measures correlate best with outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York.
- The Heart Center at Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida.
- Data Science Institute, Columbia University, New York, New York.
Zitieren
APA
Rosenzweig, E., Villeda, G. A. V., Crook, S., Koli, F., Rosenzweig, E. B., & Krishnan, U. S. (2023). Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study. Texas Heart Institute Journal. https://doi.org/10.14503/thij-22-7866
Vancouver
Rosenzweig E, Villeda GAV, Crook S, Koli F, Rosenzweig EB, Krishnan US. Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study. Texas Heart Institute Journal. 2023. doi:10.14503/thij-22-7866
BibTeX
@article{Rosenzweig2023,
author = {Rosenzweig, Eliana and Villeda, Gerson Antonio Valencia and Crook, Sarah and Koli, Fatima and Rosenzweig, Erika B and Krishnan, Usha S},
title = {Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study},
journal = {Texas Heart Institute Journal},
year = {2023},
doi = {10.14503/thij-22-7866}
}
EUVIMED